References
- Prusiner SB. Prion Biology and Diseases 2004; Cold Spring Harbor Cold Spring Harbor Laboratory Press
- Chesebro B. Introduction to the transmissible spongiform encephalopathies or prion diseases. Br Med Bull 2003; 66:1 - 20
- Alper T, Haig DA, Clarke MC. The exceptionally small size of the scrapie agent. Biochem Biophys Res Commun 1966; 22:278 - 284
- Griffith JS. Self-replication and scrapie. Nature 1967; 215:1043 - 1044
- Dickinson AG, Meikle VMH, Fraser H. Identification of a gene which controls the incubation period of some strains of scrapie in mice. J Comp Path 1968; 78:293 - 299
- Carlson GA, Kingsbury DT, Goodman PA, Coleman S, Marshall ST, DeArmond S, Westaway D, Prusiner SB. Linkagae of prion protein and scrapie incubation time genes. Cell 1986; 46:503 - 511
- Bolton DC, McKinley MP, Prusiner SB. Identification of a protein that purifies with the scrapie prion. Science 1982; 218:1309 - 1311
- Büeler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C. Normal development and behavior of mice lacking the neuronal cell-surface PrP protein. Nature 1992; 356:577 - 582
- Stahl N, Borchelt DR, Hsiao K, Prusiner SB. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 1987; 51:229 - 240
- Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C. Mice devoid of PrP are resistant to Scrapie. Cell 1993; 73:1339 - 1347
- Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B. The most infectious prion protein particles. Nature 2005; 437:257 - 261
- Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ, Prusiner SB. Synthetic mammalian prions. Science 2004; 305:673 - 676
- Collinge J. Variant Creutzfeldt-Jakob disease. Lancet 1999; 354:317 - 323
- Cooper TG. Transmitting the signal of excess nitrogen in Saccharomyces cerevisiae from the Tor proteins to th GATA factors: Connecting the dots. FEMS Microbiol Revs 2002; 26:223 - 238
- Magasanik B, Kaiser CA. Nitrogen regulation in Saccharomyces cerevisiae. Gene 2002; 290:1 - 18
- Lacroute F. NonMendelian mutation allowing ureidosuccinic acid uptake in yeast. J Bacteriol 1971; 106:519 - 522
- Cox BS. PSI, a cytoplasmic suppressor of super-suppressor in yeast. Heredity 1965; 20:505 - 521
- Zhouravleva G, Frolova L, Le Goff X, Le Guellec R, Inge-Vechtomov S, Kisselev L, Philippe M. Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. EMBO J 1995; 14:4065 - 4072
- Stansfield I, Jones KM, Kushnirov VV, Dagkesamanskaya AR, Poznyakovski AI, Paushkin SV, Nierras CR, Cox BS, Ter-Avanesyan MD, Tuite MF. The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J 1995; 14:4365 - 4373
- Wickner RB. [URE3] as an altered URE2 protein: Evidence for a prion analog in S. cerevisiae. Science 1994; 264:566 - 569
- Drillien R, Lacroute F. Ureidosuccinic acid uptake in yeast and some aspects of its regulation. J Bacteriol 1972; 109:203 - 208
- Singh AC, Helms C, Sherman F. Mutation of the nonMendelian suppressor y+ in yeast by hypertonic media. Proc Natl Acad Sci USA 1979; 76:1952 - 2016
- Lund PM, Cox BS. Reversion analysis of [psi-] mutations in Saccharomyces cerevisiae. Genet Res 1981; 37:173 - 182
- Chernoff YO, Derkach IL, Inge-Vechtomov SG. Multicopy SUP35 gene induces de novo appearance of psi-like factors in the yeast Saccharomyces cerevisiae. Curr Genet 1993; 24:268 - 270
- Masison DC, Wickner RB. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science 1995; 270:93 - 95
- Masison DC, Maddelein ML, Wickner RB. The prion model for [URE3] of yeast: Spontaneous generation and requirements for propagation. Proc Natl Acad Sci USA 1997; 94:12503 - 12508
- Ter-Avanesyan MD, Dagkesamanskaya AR, Kushnirov VV, Smirnov VN. The SUP35 omnipotent suppressor gene is involved in the maintenance of the nonMendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. Genetics 1994; 137:671 - 676
- Doel SM, McCready SJ, Nierras CR, Cox BS. The dominant PNM2-mutation which eliminates the [PSI] factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics 1994; 137:659 - 670
- DePace AH, Santoso A, Hillner P, Weissman JS. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 1998; 93:1241 - 1252
- Liu JJ, Lindquist S. Oligopeptide-repeat expansions modulate ‘protein-only’ inheritance in yeast. Nature 1999; 400:573 - 576
- Maddelein ML, Wickner RB. Two Prion-inducing regions of Ure2p are nonoverlapping. Mol Cell Biol 1999; 19:4516 - 4524
- Kochneva-Pervukhova NV, Paushkin SV, Kushnirov VV, Cox BS, Tuite MF, Ter-Avanesyan MD. Mechanism of inhibition of Y+ prion determinant propagation by a mutation of the N-terminus of the yeast Sup35 protein. EMBO J 1998; 17:5805 - 5810
- Borchsenius AS, Wegrzyn RD, Newnam GP, Inge-Vechtomov SG, Chernoff YO. Yeast prion protein derivative defective in aggregate shearing and production of new ‘seeds’. EMBO J 2001; 20:6683 - 6691
- Ross ED, Baxa U, Wickner RB. Scrambled prion domains form prions and amyloid. Mol Cell Biol 2004; 24:7206 - 7213
- Ross ED, Edskes HK, Terry MJ, Wickner RB. Primary sequence independence for prion formation. Proc Natl Acad Sci USA 2005; 102:12825 - 12830
- Kochneva-Pervukhova NV, Poznyakovski AI, Smirnov VN, Ter-Avanesyan MD. C-terminal truncation of the Sup35 protein increases the frequency of de novo generation of a prion-based [PSI+] determinant in Saccharmyces cerevisiae. Curr Genet 1998; 34:146 - 151
- Pierce MM, Baxa U, Steven AC, Bax A, Wickner RB. Is the prion domain of soluble Ure2p unstructured?. Biochemistry 2005; 44:321 - 328
- Lansbury PT, Costa PR, Griffiths JM, Simon EJ, Auger M, Halverson KJ, Kocisko DA, Hendsch ZS, Ashburn TT, Spencer RG, et al. Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nat Struct Biol 1995; 2:990 - 998
- Benzinger TL, Gregory DM, Burkoth TS, Miller-Auer H, Lynn DG, Botto RE, Meredith SC. Propagating structure of Alzheimer's β-amyloid(10–35) is parallel β-sheet with residues in exact register. Proc Natl Acad Sci USA 1998; 95:13407 - 13412
- Antzutkin ON, Balbach JJ, Leapman RD, Rizzo NW, Reed J, Tycko R. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of β-sheets in Alzheimer's β-amyloid fibrils. Proc Natl Acad Sci USA 2000; 97:13045 - 13050
- Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, Tycko R. A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 2002; 99:16742 - 16747
- Tycko R. Insights into the amyloid folding problem from solid-state NMR. Biochemistry 2003; 42:3151 - 3159
- Jayasinghe SA, Langen R. Identifying structural features of fibrillar islet amyloid polypeptide using site-directed spin labeling. J Biol Chem 2004; 279:48420 - 48425
- Der-Sarkissian A, Jao CC, Chen J, Langen R. Structural organization of a-synuclein fibrils studied by site-directed spin labeling. J Biol Chem 2003; 278:37530 - 37535
- Yoder MD, Jurnak F. Protein motifs: 3. The parallel β helix and other coiled folds. FASEB J 1995; 9:335 - 342
- Perutz MF, Johnson T, Suzuki M, Finch JT. Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci USA 1994; 91:5355 - 5358
- Ross ED, Minton AP, Wickner RB. Prion domains: Sequences, structures and interactions. Nat Cell Biol 2005; 7:1039 - 1044
- Taylor KL, Cheng N, Williams RW, Steven AC, Wickner RB. Prion domain initiation of amyloid formation in vitro from native Ure2p. Science 1999; 283:1339 - 1343
- Baxa U, Taylor KL, Wall JS, Simon MN, Cheng N, Wickner RB, Steven AC. Architecture of Ure2p prion filaments: The N-terminal domain forms a central core fiber. J Biol Chem 2003; 278:43717 - 43727
- Chan JC, Oyler NA, Yau WM, Tycko R. Parallel β-sheets and polar zippers in amyloid fibrils formed by residues 10–39 of the yeast prion protein Ure2p. Biochemistry 2005; 44:10669 - 10680
- Baxa U, Speransky V, Steven AC, Wickner RB. Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein. Proc Natl Acad Sci USA 2002; 99:5253 - 5260
- Bai M, Zhou JM, Perrett S. The yeast prion protein Ure2 shows glutathione peroxidase activity in both native and fibrillar forms. J Biol Chem 2004; 279:50025 - 50030
- Maddelein ML, Dos Reis S, Duvezin-Caubet S, Coulary-Salin B, Saupe SJ. Amyloid aggregates of the HET-s prion protein are infectious. Proc Natl Acad Sci USA 2002; 99:7402 - 7407
- King CY, Diaz-Avalos R. Protein-only transmission of three yeast prion strains. Nature 2004; 428:319 - 323
- Tanaka M, Chien P, Naber N, Cooke R, Weissman JS. Conformational variations in an infectious protein determine prion strain differences. Nature 2004; 428:323 - 328
- Brachmann A, Baxa U, Wickner RB. Prion generation in vitro: Amyloid of Ure2p is infectious. EMBO J 2005; 24:3082 - 3092
- Petkova AT, Leapman RD, Guo Z, Yau WM, Mattson MP, Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 2005; 307:262 - 265
- Eaglestone SS, Cox BS, Tuite MF. Translation termination efficiency can be regulated in Saccharomyces cerevisiae by environmental stress through a prion-mediated mechanism. EMBO J 1999; 18:1974 - 1981
- True HL, Berlin I, Lindquist SL. Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits. Nature 2004; 431:184 - 187
- True HL, Lindquist SL. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 2000; 407:477 - 483
- Nakayashiki T, Kurtzman CP, Edskes HK, Wickner RB. Yeast prions [URE3] and [PSI+] are diseases. Proc Natl Acad Sci USA 2005; 102:10575 - 10580
- Wickner RB. Knipe DM, Howley PM. Fields Virology 2001; Philadelphia Lippincott, Williams and Wilkins 629 - 658
- Mead DJ, Gardner DCJ, Oliver SG. The yeast 2 m plasmid: Strategies for the survival of a selfish DNA. Mol Gen Genet 1986; 205:417 - 421
- Resende CG, Outeiro TF, Sands L, Lindquist S, Tuite MF. Prion protein gene polymorphisms in Saccharomyces cerevisiae. Mol Microbiol 2003; 49:1005 - 1017
- Chernoff YO, Galkin AP, Lewitin E, Chernova TA, Newnam GP, Belenkiy SM. Evolutionary conservation of prion-forming abilities of the yeast Sup35 protein. Mol Microbiol 2000; 35:865 - 876
- Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136 - 144
- Jones EW. Three proteolytic systems in the yeast Saccharomyces cerevisiae. J Biol Chem 1991; 266:7963 - 7966
- Zubenko GS, Park FJ, Jones EW. Genetic properties of mutations at the PEP4 locus in Saccharomyces cerevisiae. Genetics 1982; 102:679 - 690
- Roberts BT, Wickner RB. A class of prions that propagate via covalent auto-activation. Genes Dev 2003; 17:2083 - 2087
- Coustou V, Deleu C, Saupe S, Begueret J. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc Natl Acad Sci USA 1997; 94:9773 - 9778
- Silar P, Haedens V, Rossingnol M. Propagation of a novel cytoplasmic, infectious and deleterious determinant is controlled by translational accuracy in Podospora anserina. Genetics 1999; 151:87 - 95
- Kicka S, Silar P. PaASK1, a mitogen-activated protein kinase kinase kinase that controls cell degeneration and cell differentiation in Podospora anserina. Genetics 2004; 166:1241 - 1252
- Wickner RB, Edskes HK, Ross ED, Pierce MM, Shewmaker F, Baxa U, Brachmann A. Prions of yeast are genes made of protein: Amyloids and enzymes. Cold Spring Harb Symp Quant Biol 2004; 49:489 - 496